Fintech PR
Futu’s FY2020 net income hits HK$[1],364M, 6.5 times YoY growth

Operational highlights of the unaudited financial results for the fourth quarter and the full year ended December 31, 2020
- Total revenue in the fourth quarter was HK$1,186.4 million, an increase of 281.6% year-on-year (“YoY”), achieving a YoY triple-digit growth for four consecutive quarters.
- For the full year 2020, Futu Holdings’ total revenues increased by 211.9% YoY to HK$3,310.8 million, and Non-GAAP adjusted net income[1] increased 651.1% YoY to HK$1,364.0 million.
- The number of users reached 11.9 million, an increase of 58.6% YoY; the number of clients reached 1,419,734, an increase of 97.8% YoY; the number of Futu’s paying clients reached 516,721, an increase of 160.5% YoY.
- During the period, the trading volume of Futu US stocks ballooned to HK$783.6 billion, surpassing the US$100 billion milestone for the first time, accounting for 65% of the total trading volume.
Futu Holdings Limited (“Futu” or the “Company”) (NASDAQ: FUTU), a leading tech-driven online brokerage and wealth management platform, announces its unaudited financial results for the fourth quarter (“Q4” or the “Period”) and full year ended December 31, 2020.
During the period, total revenues reached HK$1,186.4 million, an increase of 281.6% YoY, the fourth consecutive quarter of a YoY triple-digit growth. Non-GAAP adjusted net income was up 10.2 times year-over-year to HK$552.9 million. Brokerage commission and handling charge income increased 373.8% YoY to HK$718.3 million, interest income increased by 163.2% YoY to HK$336.9 million, and other income (including wealth management, enterprise services, etc.) increased by 317.8% YoY to HK$131.2 million.
For the full year of 2020, Futu’s total revenues increased by 211.9% YoY to HK$3,310.8 million. It recorded a non-GAAP adjusted net income of HK$1,364.0 million, an increase of 651.1% YoY.
As of the end of 2020, the total number of users reached 11.9 million, an increase of 58.6% YoY; the number of registered clients increased 97.8% YoY to 1,419,734; the number of paying clients increased 160.5% YoY to 516,721. In the fourth quarter, the Company added 98,632 paying clients on a net basis; the number of paying clients in Hong Kong increased by 260% YoY, setting a record high quarterly since listing, and achieving triple-digit year-on-year growth for four consecutive quarters.
As of December 31, 2020, total client assets reached HK$285.2 billion, a YoY increase of 227.3%. While the number of clients is growing rapidly, the client retention rate continued to be maintained at a high level of 98% in 2020. In the fourth quarter, clients’ active trading activity was also further propelled, as Daily Average Revenue Trades (DARTs) increased 339.9% YoY to 462,261.
US stocks business spikes, quarter trading volume exceeded 100 billion US dollars
During the period, Futu’s total trading volume increased 438.1% YoY to HK$1,210.0 billion, in which trading volume for US stocks was HK$783.6 billion, marking a new milestone of exceeding US$100 billion, and accounting for 65% of the total trading volume. Futu has therefore further consolidated its position as a leading one-stop global investment APP.
Being the one-stop investment platform that integrates investment transactions, up-to-date news, real-time market data, and trading community interaction, Futu has become the preferred platform for portfolio diversification among global investors. From market accessibility perspectives, and after years of endeavor in R&D, Futu was the first online brokerage to offer users free Level 2 market data for US stocks. Futu’s extended trading hour service enabled clients to capture investment opportunities with ease. Meanwhile, Futu News is one of the few platforms providing 24/7 US market updates, where global financial news and stock analysis are all at users’ fingertips. Further propelled by an active investment community wherein tens of millions of users seamlessly exchange thoughts and ideas to help make informed investment decisions, Futu’s US stock business continues to thrive.
Multiple licenses covering extensive areas, enters Singapore market to further expand international presence
Futu is committed to extending its licenses and qualifications in widening its product and service offerings. During the period, Futu gained approval on providing grey market services to intermediaries on the basis of the “Provide Automated Trading Services (Type 7) License” from SFC, enabling Futu to become the upstream provider of grey market trading services and offering other brokerages access to Futu’s self-developed grey market system. Futu also obtained the Singapore Capital Markets Services (CMS) License in the fourth quarter. Futu Holdings’ subsidiaries have held 35 financial licenses and qualifications in Hong Kong, the United States, Singapore as well as Europe, with footholds across major financial markets worldwide.
With its edges expanding via multiple license acquisition, Futu is vigorously advancing its internationalization strategy. In the first quarter of 2021, Futu officially entered the Singapore market, providing local investors with a seamless one-stop online trading experience, and bridging them to major global financial markets. In support of its international expansion, Futu will continue to ramp up its marketing and further strengthen its presence in the US market.
Mr. Leaf Hua Li, Futu’s Founder, Chairman, CEO & Chairman of the Technology Committee, said: “Futu sees Singapore as the key market for expansion next. Being well-positioned as the financial hub in Southeast Asia, Singapore provides a cohesive environment for FinTech development, serving as a pivot for Futu to expand our footprints to other SEA countries. We hope to establish a presence in Singapore with the provision of unparalleled investment experience to local users. Indeed, the market structure of Singapore and Hong Kong is similar. Both share the similar advantages of being an international financial center, situated within the same time zone and having dense populations. I am confident that we can make a difference in Singapore by leveraging on the successful experience we earned from the Hong Kong market.”
Enterprise Services continues to grow in prominence, helping 100+ companies listed in Hong Kong and the US
As the preferred Internet brokerage for listing on the US and Hong Kong markets, Futu’s Enterprise Services business brand, FUTU I&E, continued to be the go-to enterprise service partner. During the period, it helped numerous companies including MINISO, Lufax, Yatsen Holding, Blue Moon and JD Health successfully land in the US and Hong Kong stock markets. Futu I&E has provided IPO distribution services and investor relations services for 105 companies. Aggregating over ten million high-quality users with ample client assets, and diversified interaction design, Futu is leading the next-generation of IR services which allow companies to precisely promote their investment values to targeted audiences in an effective manner. 22 companies featured on the Futu HK$10bn+ Subscriptions IPO Roster as of year end 2020.
In the fourth quarter, Futu I&E’s ESOP option management clients accumulated to 159, including industry leaders across various industries such as healthcare & medical, consumer & retail, automotive & logistics, and TMT, namely RemeGen, POP MART, Xpeng Motors and KE Holdings Inc. By providing new economy and traditional enterprises with one-stop ESOP management services from planning, trust and taxation services, data management and exercise, Futu I&E has become the preferred one-stop ESOP services provider for leading companies among different sectors.
Seamlessly integrated wealth management and trading accounts, Money Plus’s AUM marks HK$10 billion benchmark
For its wealth management business, Money Plus has undergone a brand refresh during the period. Total client assets in Money Plus was HK$10.2 billion, highlighted with a cumulative total return of over HK$300 million for clients. As of the end of 2020, a total of nearly 110,000 clients have purchased Futu Money Plus’s fund products. As of the fourth quarter, Money Plus has established partnerships with 39 asset managers around the world, which altogether hosted 39 live-streaming sessions on the Futubull platform in 2020 to conduct fund publicity and investor education.
With rising numbers of clients leveraging on fund products to capture opportunities from equity markets, wealth management positions held continued to grow. Among them, equity fund themes, including Greater China, technology and new energy, were highly sought by clients. Augmented by dedicated in-house research efforts in picking selected funds, multiple funds available on Futu’s platform recorded over 100% returns in 2020, generating considerable returns for clients.
Fintech PR
MBZUAI Launches Institute of Foundation Models and Establishes Silicon Valley AI Lab

SAN FRANCISCO, May 23, 2025 /PRNewswire/ — Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has expanded its global footprint with the launch of its Institute of Foundation Models (IFM). The IFM is a multi-site initiative consisting of a newly established Silicon Valley Lab in Sunnyvale, CA, combined with previously announced lab facilities in Paris and Abu Dhabi.
The launch event yesterday at the Computer History Museum in Mountain View, establishes the third node in its global research network. This strategic expansion connects the university with California’s vibrant ecosystem of AI researchers, startups, and tech companies.
For the UAE and MBZUAI, this move represents another strategic step in the country’s long-term economic diversification plan. By investing in cutting-edge technologies like advanced AI foundation models, the UAE continues to build knowledge-based sectors to support its long-term economic and social transformation efforts.
“Today’s launch of the IFM represents a major step forward for the collaboration and global development of frontier-class AI foundation models,” said Professor Eric Xing, President and University Professor, MBZUAI. “Our expansion into Silicon Valley provides a critical footprint to grow our presence in one of the most vibrant AI ecosystems in the world. We’re creating pathways for knowledge exchange with leading institutions and accessing a talent pool that understands how to scale research into real-world applications.”
The launch event drew representatives from the world’s leading AI companies and academic institutions, highlighting the growing interest in MBZUAI’s global approach to foundation model research.
At the heart of MBZUAI’s demonstrations was PAN, a world model capable of infinite simulations of diverse realities ranging from basic physical interactions to complex agent scenarios.
Unlike previous systems focused primarily on generating text, audio, or images, PAN predicts comprehensive world states by integrating multimodal inputs like language, video, spatial data, and physical actions. This enables advanced reasoning, strategic planning, and nuanced decision-making for applications from autonomous driving to robotics.
PAN’s innovative hierarchical architecture supports multi-level reasoning and real-time interaction within simulations, maintaining high accuracy over extended scenarios. Its companion, PAN-Agent, showcases its utility in multimodal reasoning tasks, such as mathematics and coding, within dynamic simulated environments.
K2 and JAIS: Advanced Foundation Models with Global Impact
The IFM lab is also advancing two flagship AI systems demonstrating the commitment to further advance frontier-class foundation models: K2 and JAIS.
A soon to be released update to K2-65B will focus on delivering breakthrough reasoning capabilities with sustainable performance.
JAIS stands as the world’s most advanced Arabic large language model. At the IFM JAIS will continue to expand in capability with increased language support and add more context to preserve and promote the cultures it supports.
Building AI in the Open: Transparency as a Core Value
MBZUAI has established one of the industry’s most transparent approaches to AI development, open-sourcing not just models but entire development processes—positioning IFM as a leader in building openly. The LLM360 initiative provides researchers with complete materials including training code, datasets, and model checkpoints. This openness is balanced with safeguards including international advisory boards and peer review processes that maintain research integrity.
The IFM’s structure includes dedicated teams focused on model architecture, training methods, evaluation frameworks, and safety systems—combining the agility of a startup with the resources of an established research institution.
About Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)
MBZUAI is a research-focused university in Abu Dhabi, and the first university dedicated entirely to the advancement of science through AI. For more information, visit www.mbzuai.ac.ae.
For press inquiries:
Aya Sakoury
Head of PR and Strategic Communications
[email protected]
Photo: https://mma.prnewswire.com/media/2695164/MBZUAI.jpg
View original content:https://www.prnewswire.co.uk/news-releases/mbzuai-launches-institute-of-foundation-models-and-establishes-silicon-valley-ai-lab-302464311.html
Fintech PR
AI Could Add $461 Billion to Global Healthcare–And These New Platforms Are Leading the Charge
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, May 23, 2025 /PRNewswire/ — Equity Insider News Commentary – A new report from Philips reveals a growing divide between doctors and patients when it comes to AI in healthcare. While 63% of surveyed healthcare professionals believe AI can help improve outcomes, only 48% of patients share that optimism. As researchers explore what’s needed for successful AI adoption in healthcare, major players in tech and biotech are already moving ahead—recent updates have come from Avant Technologies, Inc. (OTCQB: AVAI), Renovaro Inc. (NASDAQ: RENB), Certara, Inc. (NASDAQ: CERT), CareCloud, Inc. (NASDAQ: CCLD), and Microsoft Corporation (NASDAQ: MSFT).
Analysts at MarketsandMarkets expect the AI healthcare sector to grow at a 38.6% CAGR, topping $110 billion by 2030. Accenture goes even further, estimating AI could inject another $461 billion in added value by 2035—amplifying impact across a global healthcare system already on track to surpass $2.26 trillion.
Avant Technologies, Inc. (OTCQB: AVAI), in partnership with Ainnova Tech, is positioning its Vision AI platform at the forefront of predictive healthcare. The company is in advanced discussions to acquire or exclusively license a patented early disease detection technology that could significantly enhance its diagnostic capabilities. If finalized, the deal would allow Vision AI to generate clinical insights even in the absence of a complete patient dataset—unlocking earlier intervention opportunities and supporting a more proactive model of care.
“Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily,” said Vinicio Vargas, CEO at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp. (AAC), said of AAC’s aim to continue to add to its portfolio. “We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem. To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions.”
The potential acquisition aligns with Avant and Ainnova’s shared mission to deliver scalable, preventive health tools that merge retinal imaging, vital sign monitoring, and machine learning into one streamlined platform. Vision AI is already positioned as a next-generation diagnostic engine for chronic conditions like diabetes, cardiovascular disease, and kidney dysfunction. Now, the joint venture is pushing further—evaluating breakthrough technologies that could detect emerging health issues at a pre-symptomatic stage.
Recent platform updates saw four proprietary algorithms—trained on over 2.3 million real-world clinical cases—fully integrated into Vision AI. The addition of new IP from this proposed deal would mark a significant leap forward, enabling predictive models to extract meaningful signals from even limited patient data.
Avant and Ainnova view this initiative as part of a broader strategy to consolidate breakthrough tools that make early disease detection more scalable, mobile, and applicable across diverse healthcare settings. While a final agreement has yet to be announced, the companies have stated they will keep shareholders informed as developments progress.
In parallel, Avant has entered formal discussions to acquire Ainnova outright—building on their existing alignment under the Ai-nova Acquisition Corp. (AAC) structure. The timing is deliberate, coming just ahead of a planned FDA pre-submission meeting this July. A completed merger would unify operations, reduce internal complexity, and bolster the joint venture’s regulatory readiness as it prepares for potential U.S. market entry.
“We believe bringing the two companies together will offer tremendous value for shareholders,” said Vargas. “It will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally.”
At the center of this initiative is Vision AI—a non-invasive screening platform that integrates retinal imaging, vital sign monitoring, and machine-learning models to flag early indicators of chronic disease. The system targets conditions such as diabetic retinopathy, cardiovascular issues, kidney and liver disorders, and type 2 diabetes. Operated under the AAC structure, the joint venture holds global rights to Vision AI, which has demonstrated over 90% sensitivity in early detection based on research cited by the NIH.
“This milestone reflects our two-tiered strategy, rapid deployment in low-regulation markets where Vision AI operates as a screening tool, and simultaneous progress toward FDA clearance for the U.S. market,” said Vargas. “Entering the U.S. will unlock significant commercial potential, and early engagement with regulators ensures we do so with speed, credibility, and a validated product.”
While many AI healthcare platforms remain stuck in pilot stages, Avant’s Vision AI is already live across multiple Latin American markets—including Chile, Mexico, and Brazil—where it’s actively being used in clinical settings. These real-world deployments are generating essential data on safety and efficacy, while also providing user feedback that guides ongoing system improvements.
To broaden its diagnostic reach, the Ai-nova joint venture recently integrated four additional algorithms into the platform. Each was trained on a dataset of more than 2.3 million clinical records, enhancing Vision AI’s precision across a wider spectrum of chronic diseases. With active momentum abroad and U.S. regulatory discussions now underway, Avant’s trajectory appears to be moving from early validation toward broader market penetration.
CONTINUED… Read this and more news for Avant Technologies at:
Renovaro Inc. (NASDAQ: RENB) has officially launched Augusta, a next-generation AI-powered platform targeting precision neurology. Designed for patient stratification, biomarker discovery, and accelerated drug development, Augusta integrates multiomics, contingent AI, phenoclustering, and in silico screening into one modular system.
“The Augusta platform is about validation,” said David Weinstein, CEO of Renovaro Inc. “We’re setting a new bar for how AI can be responsibly and effectively deployed in clinical and experimental settings.”
The platform has already demonstrated early success in Parkinson’s disease and epilepsy, with expansion plans underway for additional neurological conditions.
Certara, Inc. (NASDAQ: CERT) has launched its Non-Animal Navigator™ solution to help drug developers reduce reliance on animal testing, aligning with the FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies.
“The FDA announcement and roadmap pave the way for more model-informed drug development approaches that are predictive, efficient, and ethical,” said William F. Feehery, CEO of Certara Inc. “It is part of a growing industry adoption trend to use scientifically robust new approach methodologies (NAMs) like AI-enabled biosimulation to improve strategic decision-making and success rates at every phase of drug development.”
The new offering combines strategic regulatory guidance with AI-enabled biosimulation, providing an ethical and efficient pathway through early-stage drug development. With adoption already underway, Certara’s platform offers a future-ready model for companies advancing biologics, including monoclonal antibodies and ADCs.
CareCloud, Inc. (NASDAQ: CCLD) has been named Maxim Group’s “Top Healthcare IT Pick for 2025,” with analysts citing the company’s AI-first strategy, strong financial performance, and discounted valuation as key drivers.
“AI is now deeply integrated into our operations—from documentation and revenue cycle management to patient engagement and analytics,” said Hadi Chaudhry, Co-CEO of CareCloud Inc. “This is not an add-on, it is a foundational capability that is changing how healthcare is delivered and experienced.”
The firm recently launched its AI Center of Excellence and introduced purpose-built tools like cirrusAI Notes and cirrusAI Voice to streamline clinical workflows and improve patient engagement. CareCloud plans to scale its AI team from 50 to 500 by year-end, deepening its role as a leader in applied healthcare AI.
Microsoft Corporation (NASDAQ: MSFT) has introduced its healthcare agent orchestrator—a multi-agent AI framework designed to support complex clinical workflows, such as tumor boards, by analyzing multimodal data across imaging, genomics, and electronic health records.
“The vision of the healthcare agent orchestrator is to rapidly surface, summarize, and take action on relevant multimodal medical information for each complex cancer case, so hours of review can become minutes,” said Dr. Joshua Warner, Radiologist at UW Health and Assistant Professor of Radiology, UW School of Medicine and Public Health. “Collaborating with Microsoft allows us to explore the value of these models for tumor boards and beyond.”
Now available through Azure AI Foundry, the system enables clinicians and developers to coordinate specialized AI agents directly within Microsoft Teams and Office tools, streamlining hours of expert analysis into minutes. Leading institutions like Stanford, Johns Hopkins, and Providence are already piloting the technology to accelerate cancer diagnosis, clinical trial matching, and treatment planning.
CONTACT:
Equity Insider
[email protected]
(604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Video – https://mma.prnewswire.com/media/2695138/Equity_Insider.mp4
Logo – https://mma.prnewswire.com/media/2644233/5335696/Equity_Insider_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ai-could-add-461-billion-to-global-healthcareand-these-new-platforms-are-leading-the-charge-302464291.html
Fintech PR
Trading With Confidence: Bybit Offers Zero-Loss Coverage and Educational Rewards

DUBAI, UAE, May 23, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has renewed its offers for trading beginners in a bundle of first-trade coverage and rewards this summer. The five-track Fearless Futures initiative has something to offer in every stage of crypto trading—from research to futures trading.
Modeled after fitness coaching, Fearless Futures is a supportive package for fresh traders and learners starting their crypto trading journey. The comprehensive loss protection and rewards program offers derisking opportunities for first-time traders in sync with the market-wide rally, with BTC pushing above 100K and ETH regaining investor favor. Sophisticated product suites and knowledge sharing are becoming increasingly accessible to everyday traders, and Bybit continues to support the crypto community with professional-grade tools and flawless execution with millisecond precision.
From now until June 30 or until prize pools are fully unlocked, eligible Bybit users will enjoy exclusive protection and rewards as they advance their trading levels:
- A Zero-Risk Introduction to Futures Trading: Eligible user’s first Futures trade will be covered up to 50 USDT at Bybit should a loss occur. Vouchers are available for first-time Futures traders on Bybit until June 30, 2025.
- Carefree Copy Trading: New followers of Master Traders may claim up to 100 USDT in loss protection for Copy Trading. This welcome offer not only takes away the pressure of strategizing, but also reduces volatility risks. Copy Trading Vouchers can be used as margin and are up for grabs until December 30, 2025.
- Gold & FX Copy Trading: Another Copy Trading product tailored for Gold and FX matched the limited-time offer for first-time traders until June 30, 2025.
- It Pays to Learn: Before diving into trading, beginners may explore Bybit’s Read-to-Earn initiative and get the basics down while dividing up a 18,000 USDT prize pool.
- Bonus Community Challenge: Signing up for the Bybit Learn Community will qualify eligible users for the Community Futures Challenge. The gamified experience incentivizes knowledge sharing and community engagement with a 2,500 USDT weekly prize pool, to be shared by top contributors in the leaderboard.
The campaign benefits Bybit users at a strategic juncture when the crypto market continues its upward trajectory. Supporting the broader crypto community since 2018, Bybit aspires to help its users navigate volatility responsibly, become better traders, and be part of their progress.
Registration and task fulfilments are required, and terms and conditions apply. For details, users may visit: Fearless Futures | Trade with Confidence, Not Consequence.
#Bybit / #TheCryptoArk
About Bybit
Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open, and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.
For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: [email protected]
For updates, please follow: Bybit’s Communities and Social Media
Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Photo – https://mma.prnewswire.com/media/2695073/Trading_With_Confidence_Bybit_Offers_Zero_Loss_Coverage_Educational_Rewards.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/trading-with-confidence-bybit-offers-zero-loss-coverage-and-educational-rewards-302464289.html
-
Fintech PR7 days ago
Forbes Recognizes DXC’s Consulting Excellence in 2025 World’s Best Management Consulting Firms Ranking
-
Fintech PR7 days ago
New Healthcare AI Models Could Reshape Everything From Burnout to Diagnostics
-
Fintech7 days ago
Fintech Pulse: Your Daily Industry Brief – May 16, 2025: Mastercard, MoonPay, Méliuz, CrediLinq, PaySaxas
-
Fintech PR4 days ago
CoinW Unveils Industry-First Futures Protection Program:Instant Refunds Designed to Safeguard Traders
-
Fintech4 days ago
Fintech Pulse: Your Daily Industry Brief – May 19, 2025 (Ripple, Klarna, Etops, Finanzportal24, Revolut, Travelgate, Mize)
-
Fintech3 days ago
Fintech Pulse: Your Daily Industry Brief – May 20, 2025 | Robinhood vs IBKR, Ontik, Islamic Finance, Ant Group, Nuvei
-
Fintech PR23 hours ago
High Profile Cyberattacks Continue to Spur Rapid Adoption of Payment Tokenization Solutions to US$1 Billion Market
-
Fintech PR4 days ago
Ho Chi Minh city promotes its tourism potential in Germany